CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Autor: Hammitzsch, Ariane, Tallant, Cynthia, Fedorov, Oleg, O’Mahony, Alison, Brennan, Paul E., Hay, Duncan A., Martinez, Fernando O., Al-Mossawi, M. Hussein, de Wit, Jelle, Vecellio, Matteo, Wells, Christopher, Wordsworth, Paul, Müller, Susanne, Knapp, Stefan, Bowness, Paul
Zdroj: Proceedings of the National Academy of Sciences of the United States of America, 2015 Aug . 112(34), 10768-10773.
Databáze: JSTOR Journals